Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Ovanti

    MCap

    AUD17m

    Last close

    AUD0.00

    ▲ 0.00 (50.00%)

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

    Okyo Pharma

    MCap

    USD104m

    Last close

    USD2.76

    ▲ 0.44 (18.97%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Bull, Bear & Beyond – Newron Pharmaceuticals: executive interview

Bull, Bear & Beyond – Newron Pharmaceuticals: executive interview

Newron Pharmaceuticals — 1 video in collection

More on this equity

In this video, we speak with Stefan Weber, CEO of Newron Pharmaceuticals. We discuss the company’s registrational ENIGMA-TRS Phase III programme, the setting that evenamide is targeting and the licensing deals Newron has secured. Stefan also summarises the key milestones and catalysts that investors should watch out for across the next couple of years.

Listen on your preferred podcast player below:

About Bull, Bear & Beyond: Each episode features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

< Previous
Next >

You may also be interested in these:

Healthcare

Bull, Bear & Beyond – OSE Immunotherapeutics: executive interview

Healthcare

Bull, Bear & Beyond – Percheron Therapeutics: executive interview